Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
2.
Osteoporos Int ; 22(2): 731-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20552327

ABSTRACT

UNLABELLED: Treatment of benign prostate hyperplasia with α-blockers may affect blood pressure while treatment with 5-α-reductase inhibitors may affect conversion of testosterone potentially leading to osteoporosis. In our study, neither 5-α-reductase inhibitors nor α-blockers were associated with negative effects on fractures, α-blockers perhaps being associated with a limited decrease in fractures. INTRODUCTION: The objective is to study fracture risk associated with drugs for benign prostate hyperplasia. The hypotheses were that (1) α-blockers may elevate fracture risk by causing presyncope/falls and (2) 5-α-reductase inhibitors may elevate fracture risk by lowering dihydrotestosterone. METHODS: This is a nationwide case-control study using all 9,719 male fracture patients aged ≥60 years in the year 2000 as cases and drawing 29,156 age- and gender-matched controls. The main exposure was the use of the drugs mentioned above for benign prostate hyperplasia. Confounder control included social variables, contacts to hospitals and general practitioners, alcoholism and other variables. RESULTS: For the 5-α-reductase inhibitors, no change in overall risk of fractures was seen. No change in risk of hip, spine and forearm fractures was present. For the α-blockers, a decrease in overall risk of fractures was seen, as well as a decrease in the risk of hip and spine fractures, but only at average doses >0.5 defined daily doses per day. No decrease was seen for forearm fractures. A decreasing risk of any fracture, hip fractures and spine fractures were seen with increasing dose of α-blockers, while no such association was seen for the forearm fractures. CONCLUSION: Neither the 5-α-reductase inhibitors nor α-blockers were associated with negative effects on fracture risk. A small trend towards a decrease in fracture risk may be present for the α-blockers. However, more research is needed to confirm if this trend is real.


Subject(s)
5-alpha Reductase Inhibitors/adverse effects , Adrenergic alpha-Antagonists/adverse effects , Forearm Injuries/chemically induced , Hip Fractures/chemically induced , Prostatic Hyperplasia/drug therapy , Spinal Fractures/chemically induced , 5-alpha Reductase Inhibitors/administration & dosage , Adrenergic alpha-Antagonists/administration & dosage , Aged , Aged, 80 and over , Case-Control Studies , Humans , Male , Risk Factors , Treatment Outcome
4.
Osteoporos Int ; 18(4): 409-17, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17093893

ABSTRACT

BACKGROUND: Cardiac arrhythmias and osteoporotic fractures are common in the elderly. AIM: We studied whether tachyarrhythmia and/or the drugs used to treat arrhythmias affect risk of fracture. METHODS: In a population-based nation-wide pharmaco-epidemiological case-control design, we compared 124,655 patients that sustained a fracture during 2000 with 373,962 age- and gender-matched controls. We used computerized registers to assess individual drug use and related these data to individual fracture data and information on confounders. RESULTS: Risk of any fracture was increased in patients with atrial fibrillation [Odds ratio (OR): 1.14; 95% confidence interval (95%CI): 1.08-1.21] and in patients currently treated with amiodarone (OR: 1.47; 95%CI: 1.21-1.78). Conversely, current use of digoxin decreased fracture risk (OR: 0.75; 95%CI: 0.71-0.79). Subanalysis showed similar effects in men and in women, but drug treatment only affected fracture risk in subjects older than 65 years of age. In current users of digoxin, risk of any fracture and risk of hip and forearm fracture decreased dose-dependently with increased dose. The use of other antiarrhythmics did not affect fracture risk. CONCLUSION: Special attention should be paid to patients on treatment with amiodarone and/or a diagnosis of atrial fibrillation as they may have an increased risk of fracture. Conversely, treatment with digoxin may reduce fracture risk.


Subject(s)
Amiodarone/adverse effects , Anti-Arrhythmia Agents/adverse effects , Arrhythmias, Cardiac/drug therapy , Digoxin/adverse effects , Fractures, Bone/chemically induced , Osteoporosis/complications , Adult , Age Factors , Aged , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/complications , Atrial Fibrillation/complications , Atrial Fibrillation/drug therapy , Case-Control Studies , Digoxin/therapeutic use , Dose-Response Relationship, Drug , Female , Forearm Injuries/chemically induced , Hip Fractures/chemically induced , Humans , Male , Risk Factors , Sex Factors , Tachycardia/complications , Tachycardia/drug therapy
7.
Handchir Mikrochir Plast Chir ; 34(6): 399-402, 2002 Nov.
Article in German | MEDLINE | ID: mdl-12601608

ABSTRACT

Extravasations of chemotherapeutic drugs may lead to large soft-tissue losses in the hand and forearm and necessitating surgical excision with secondary flap coverage. Unfortunately, a delayed referral to a hand and plastic surgical unit with an already established soft-tissue defect is most common. Nevertheless, in our unit the method of choice is early emergency subcutaneous "wash-out", which facilitates dilution and reduction of concentration of the extravasation and therefore reliably avoids the development of soft-tissue defects. The aim of this paper is to present the surgical technique.


Subject(s)
Antineoplastic Agents/adverse effects , Burns, Chemical/surgery , Emergencies , Extravasation of Diagnostic and Therapeutic Materials/surgery , Forearm Injuries/chemically induced , Hand Injuries/chemically induced , Therapeutic Irrigation/methods , Anesthesia, Conduction , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Capillary Permeability/drug effects , Dimethyl Sulfoxide/administration & dosage , Forearm Injuries/surgery , Hand Injuries/surgery , Humans , Hyaluronoglucosaminidase/administration & dosage , Infusions, Intravenous , Isotonic Solutions/administration & dosage , Ringer's Lactate , Sodium Chloride
8.
Ann Epidemiol ; 6(3): 209-16, 1996 May.
Article in English | MEDLINE | ID: mdl-8827156

ABSTRACT

The purpose of this study was to examine whether geographic area or water fluoride were related to the occurrence of fractures among the elderly in the United States. We used a 5% sample of the white U.S. Medicare population, aged 65 to 89 years during the period 1986-1990, to identify fractures of the hip, proximal humerus, distal forearm, and ankle. The association of geographic region and fluoridation status with fracture rates was assessed using Poisson regression. We found that rates of hip fracture were generally lower in the northern regions of the United States and higher in the southern regions. For fractures of the distal forearm and proximal humerus, lower rates were found in the Western states, and higher rates in the East. No discernible geographic pattern was found for ankle fractures. Adjustment for water fluoridation did not influence these results. Independent of geographic effects, men in fluoridated areas had modestly higher rates of fractures of the distal forearm and proximal humerus than did men in nonfluoridated areas; no such differences were observed among women, nor for fractures of the hip or ankle among either men or women. In conclusion, our data suggest that fractures of the distal forearm and proximal humerus have etiologic determinants distinct from those of fractures of the hip or ankle.


Subject(s)
Fluoridation/adverse effects , Fractures, Bone/epidemiology , Aged , Aged, 80 and over , Ankle Injuries/chemically induced , Ankle Injuries/epidemiology , Cohort Studies , Female , Forearm Injuries/chemically induced , Forearm Injuries/epidemiology , Fractures, Bone/chemically induced , Hip Fractures/chemically induced , Hip Fractures/epidemiology , Humans , Incidence , Male , Medicare/statistics & numerical data , Sampling Studies , Sex Distribution , Shoulder Fractures/chemically induced , Shoulder Fractures/epidemiology , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...